From Nasdaq: 2025-05-05 16:23:00

Today’s Zacks Research Daily features new reports on Alphabet Inc. (GOOGL), Berkshire Hathaway Inc. (BRK.B), Visa Inc. (V), and bioAffinity Technologies, Inc. (BIAF). Alphabet is riding on strong cloud and search growth, while Berkshire Hathaway benefits from a strong cash position. Visa is experiencing strong payment volumes, but bioAffinity Technologies faces risks due to regulatory uncertainty and competitive pressures.

In terms of performance, Alphabet’s shares have outperformed the Zacks Internet – Services industry, Berkshire Hathaway’s shares have gained, and Visa’s shares have outperformed the Zacks Financial Transaction Services industry. On the other hand, bioAffinity Technologies has underperformed the Zacks Medical – Biomedical and Genetics industry.

Alphabet expects to invest roughly $75 billion in capital expenditures in 2025 and surpassed 270 million paid subscriptions. Berkshire Hathaway’s continued insurance business growth drives earnings, while Visa expects net revenues to grow in high single to low double-digits in fiscal 2025. BioAffinity Technologies reported revenue growth in 2024, with projections for 2025.

In other news, Welltower is expected to gain from high senior housing demand, Ecolab’s R&D boosts growth amid market uncertainties, and Cognizant is benefiting from acquisitions and a strong partner base. Xenon is focusing on its lead epilepsy candidate, while California Water Service is benefiting from investment and organic growth. New upgrades include Fluor, Itron, and Xerox, while downgrades include ManpowerGroup, Stanley Black, and Owens Corning.

For more detailed analysis and stock recommendations, readers can access Zacks Investment Research reports for free.



Read more at Nasdaq: Top Stock Reports for Alphabet, Berkshire Hathaway & Visa